MLchartDataset catalogue

lobradimil

Term · Oncology and biomedicine · MLC-T-ONC-004898

  1. A substance that is being studied for its ability to help other drugs reach the brain. It belongs to the family of drugs called bradykinin agonists. Also called RMP-7.

  2. A synthetic analog of bradykinin. Lobradimil is a potent, specific bradykinin B-2 receptor agonist that stimulates B-2 receptors expressed on the surface of brain capillary endothelial cells, thereby reversibly increasing the permeability of the blood-brain barrier (BBB). Compared to bradykinin, this agent possesses enhanced receptor selectivity, greater plasma stability, and a longer half-life.

Table 1. Record
IdentifierMLC-T-ONC-004898
FieldOncology and biomedicine
SynonymsRMP-7
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-004898",
  "term": "lobradimil",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance that is being studied for its ability to help other drugs reach the brain. It belongs to the family of drugs called bradykinin agonists. Also called RMP-7.",
    "A synthetic analog of bradykinin. Lobradimil is a potent, specific bradykinin B-2 receptor agonist that stimulates B-2 receptors expressed on the surface of brain capillary endothelial cells, thereby reversibly increasing the permeability of the blood-brain barrier (BBB). Compared to bradykinin, this agent possesses enhanced receptor selectivity, greater plasma stability, and a longer half-life."
  ],
  "synonyms": [
    "RMP-7"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/lobradimil/"
}

Record 10,262 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.